Table 1 Patient characteristics
Characteristics | Patients (n = 46) |
|---|---|
Age, years, median (range) | 59 (35–74) |
Sex, n (%) | |
Male | 28 (60.9) |
Female | 18 (39.1) |
Immunoscore, n (%) | |
Intermediate | 39 (84.8) |
High | 7 (15.2) |
ECOG performance status, n (%) | |
0 | 19 (41.3) |
1 | 27 (58.7) |
Clinical T category, n (%) | |
cT3 | 30 (65.2) |
cT4 | 16 (34.8) |
Clinical N category, n (%) | |
cN0 | 2 (4.3) |
cN1 | 24 (52.2) |
cN2 | 20 (43.5) |
Clinical disease stage, n (%) | |
II | 2 (4.3) |
III | 44 (95.7) |
CRM, n (%) | |
Positive | 26 (56.5) |
Negative | 20 (43.5) |
EMVI, n (%) | |
Positive | 25 (54.3) |
Negative | 21 (45.7) |
Distance from primary tumor to anal verge, n (%) | |
Median (range), cm | 4.8 (2.1–9.7) |
<5 | 24 (52.2) |
5–12 | 22 (47.8) |
Length of tumor lesion, cm, median (range) | 4.3 (2.5–7.9) |
Mismatch repair status, n (%) | |
dMMR | 0 |
pMMR | 46 (100) |
Baseline CEA level, n (%) | |
Normal (<5 ng/mL) | 26 (56.5) |
Abnormal (≥5 ng/mL) | 20 (43.5) |
